메뉴 건너뛰기




Volumn 37, Issue 7, 2014, Pages 1162-1167

Effects of chebulic acid on advanced glycation endproducts-induced collagen cross-links

Author keywords

Advanced glycation end product; Antiglycation effect; Chebulic acid; Chelating activity; Collagen cross link; Terminalia chebula

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALAGEBRIUM; AMINOGUANIDINE; ANTIOXIDANT; ASCORBIC ACID; BOVINE SERUM ALBUMIN; CHEBULIC ACID; COLLAGEN; COPPER; PLANT MEDICINAL PRODUCT; UNCLASSIFIED DRUG; 2,2-DIPHENYL-1-PICRYLHYDRAZYL; ACETALDEHYDE; BENZOPYRAN DERIVATIVE; BIPHENYL DERIVATIVE; CROSS LINKING REAGENT; GLYCOLALDEHYDE; PICRIC ACID; SCAVENGER;

EID: 84904654596     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b14-00034     Document Type: Article
Times cited : (19)

References (24)
  • 2
    • 0023950461 scopus 로고
    • Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications
    • Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N. Engl. J. Med., 318, 1315-1321 (1988).
    • (1988) N. Engl. J. Med. , vol.318 , pp. 1315-1321
    • Brownlee, M.1    Cerami, A.2    Vlassara, H.3
  • 4
    • 11144324314 scopus 로고    scopus 로고
    • Advanced glycation endproducts-role in pathology of diabetic complications
    • Ahmed N. Advanced glycation endproducts-role in pathology of diabetic complications. Diabetes Res. Clin. Pract., 67, 3-21 (2005).
    • (2005) Diabetes Res. Clin. Pract. , vol.67 , pp. 3-21
    • Ahmed, N.1
  • 5
    • 0035227858 scopus 로고    scopus 로고
    • Pharmaceutical intervention of advanced glycation endproducts
    • discussion, 212-216, 217-220
    • Cerami A, Ulrich P. Pharmaceutical intervention of advanced glycation endproducts. Novartis Found. Symp., 235, 202-212, discussion, 212-216, 217-220 (2001).
    • (2001) Novartis Found. Symp. , vol.235 , pp. 202-212
    • Cerami, A.1    Ulrich, P.2
  • 6
    • 21444449221 scopus 로고    scopus 로고
    • The role of AGEs and AGE inhibitors in diabetic cardiovascular disease
    • Thomas MC, Baynes JW, Thorpe SR, Cooper ME. The role of AGEs and AGE inhibitors in diabetic cardiovascular disease. Curr. Drug Targets, 6, 453-474 (2005).
    • (2005) Curr. Drug Targets , vol.6 , pp. 453-474
    • Thomas, M.C.1    Baynes, J.W.2    Thorpe, S.R.3    Cooper, M.E.4
  • 7
    • 0022644227 scopus 로고
    • Aminoguanidine prevents diabetes-induced arterial wall protein crosslinking
    • Brownlee M, Vlassara H, Kooney A, Ulrich P, Cerami A. Aminoguanidine prevents diabetes-induced arterial wall protein crosslinking. Science, 232, 1629-1632 (1986).
    • (1986) Science , vol.232 , pp. 1629-1632
    • Brownlee, M.1    Vlassara, H.2    Kooney, A.3    Ulrich, P.4    Cerami, A.5
  • 8
    • 0142074864 scopus 로고    scopus 로고
    • Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts
    • Thornalley PJ. Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts. Arch. Biochem. Biophys., 419, 31-40 (2003).
    • (2003) Arch. Biochem. Biophys. , vol.419 , pp. 31-40
    • Thornalley, P.J.1
  • 9
    • 0035172601 scopus 로고    scopus 로고
    • Therapeutic potential of AGE inhibitors and breakers of AGE protein cross-links
    • Vasan S, Foiles PG, Founds HW. Therapeutic potential of AGE inhibitors and breakers of AGE protein cross-links. Expert Opin. Investig. Drugs, 10, 1977-1987 (2001).
    • (2001) Expert Opin. Investig. Drugs , vol.10 , pp. 1977-1987
    • Vasan, S.1    Foiles, P.G.2    Founds, H.W.3
  • 12
    • 79961098801 scopus 로고    scopus 로고
    • Effect of alagebrium, an advanced glycation endproduct breaker, on exercise tolerence and cardiac funtion in patient with chronic heart failure
    • BENEFICIAL investigators
    • Hartag JW, Willemsen S, van Veldhuisen DJ, Posma JL, van Wijk LM, Hummel YM, Hillege HL, Voovs AA, BENEFICIAL investigators. Effect of alagebrium, an advanced glycation endproduct breaker, on exercise tolerence and cardiac funtion in patient with chronic heart failure. Eur. J. Heart Fail., 13, 899-908 (2011).
    • (2011) Eur. J. Heart Fail. , vol.13 , pp. 899-908
    • Hartag, J.W.1    Willemsen, S.2    Van Veldhuisen, D.J.3    Posma, J.L.4    Van Wijk, L.M.5    Hummel, Y.M.6    Hillege, H.L.7    Voovs, A.A.8
  • 14
    • 33847662837 scopus 로고    scopus 로고
    • Isolation of chebulic acid from Terminalia chebula RETZ. and its antioxidant effect in isolated rat hepatocytes
    • Lee HS, Jung SH, Yun BS, Lee KW. Isolation of chebulic acid from Terminalia chebula RETZ. and its antioxidant effect in isolated rat hepatocytes. Arch. Toxicol., 81, 211-218 (2007).
    • (2007) Arch. Toxicol. , vol.81 , pp. 211-218
    • Lee, H.S.1    Jung, S.H.2    Yun, B.S.3    Lee, K.W.4
  • 15
    • 0031716747 scopus 로고    scopus 로고
    • Screening of some Indian medicinal plants for their antimicrobial properties
    • Ahmad I, Mehmood Z, Mohammad F. Screening of some Indian medicinal plants for their antimicrobial properties. J. Ethnopharmacol., 62, 183-193 (1998).
    • (1998) J. Ethnopharmacol. , vol.62 , pp. 183-193
    • Ahmad, I.1    Mehmood, Z.2    Mohammad, F.3
  • 16
    • 24944516156 scopus 로고    scopus 로고
    • Antioxidant effects of aqueous extract of Terminalia chebula in vivo and in vitro
    • Lee HS, Won NH, Kim KH, Lee H, Jun W, Lee KW. Antioxidant effects of aqueous extract of Terminalia chebula in vivo and in vitro. Biol. Pharm. Bull., 28, 1639-1644 (2005).
    • (2005) Biol. Pharm. Bull. , vol.28 , pp. 1639-1644
    • Lee, H.S.1    Won, N.H.2    Kim, K.H.3    Lee, H.4    Jun, W.5    Lee, K.W.6
  • 17
    • 77956647697 scopus 로고    scopus 로고
    • Preventive effects of chebulic acid isolated from Terminalia chebula on advanced glycation endproduct-induced endothelial cell dysfunction
    • Lee HS, Koo YC, Suh HJ, Kim KY, Lee KW. Preventive effects of chebulic acid isolated from Terminalia chebula on advanced glycation endproduct-induced endothelial cell dysfunction. J. Ethnopharmacol., 131, 567-574 (2010).
    • (2010) J. Ethnopharmacol. , vol.131 , pp. 567-574
    • Lee, H.S.1    Koo, Y.C.2    Suh, H.J.3    Kim, K.Y.4    Lee, K.W.5
  • 19
    • 0014949207 scopus 로고
    • Cleavage of structural proteins during assembly of head of bacteriophage T4
    • Laemmli U. Cleavage of structural proteins during assembly of head of bacteriophage T4. Nature, 227, 680-685 (1970).
    • (1970) Nature , vol.227 , pp. 680-685
    • Laemmli, U.1
  • 20
    • 84857430527 scopus 로고    scopus 로고
    • Chelation: A fundamental mechanism of action of AGE inhibitors, AGE breakers, and other inhibitors of diabetes complications
    • Nagai R, Murray DB, Metz TO, Baynes JW. Chelation: A fundamental mechanism of action of AGE inhibitors, AGE breakers, and other inhibitors of diabetes complications. Diabetes, 61, 549-559 (2012).
    • (2012) Diabetes , vol.61 , pp. 549-559
    • Nagai, R.1    Murray, D.B.2    Metz, T.O.3    Baynes, J.W.4
  • 21
    • 42049118293 scopus 로고    scopus 로고
    • The role of advanced glycation end products in progression and complications of diabetes
    • Goh SY, Cooper ME. The role of advanced glycation end products in progression and complications of diabetes. J. Clin. Endocrinol. Metab., 93, 1143-1152 (2008).
    • (2008) J. Clin. Endocrinol. Metab. , vol.93 , pp. 1143-1152
    • Goh, S.Y.1    Cooper, M.E.2
  • 22
    • 0035966113 scopus 로고    scopus 로고
    • Chelating activity of advanced glycation end-product inhibitors
    • Price DL, Rhett PM, Thorpe SR, Baynes JW. Chelating activity of advanced glycation end-product inhibitors. J. Biol. Chem., 276, 48967-48972 (2001).
    • (2001) J. Biol. Chem. , vol.276 , pp. 48967-48972
    • Price, D.L.1    Rhett, P.M.2    Thorpe, S.R.3    Baynes, J.W.4
  • 23
    • 79959992844 scopus 로고    scopus 로고
    • Inhibitory effects of Terminalia chebula extract on glycation and endothelial cell adhesion
    • Lee HS, Cho HY, Park KW, Kim IH, Kim JT, Nam MH, Lee KW. Inhibitory effects of Terminalia chebula extract on glycation and endothelial cell adhesion. Planta Med., 77, 1060-1067 (2011).
    • (2011) Planta Med. , vol.77 , pp. 1060-1067
    • Lee, H.S.1    Cho, H.Y.2    Park, K.W.3    Kim, I.H.4    Kim, J.T.5    Nam, M.H.6    Lee, K.W.7
  • 24
    • 77249139924 scopus 로고    scopus 로고
    • Citric acid inhibits development of cataracts, proteinuria and ketosis in streptozotocin (type 1) diabetic rats
    • Nagai R, Nagai M, Shimasaki S, Baynes JW, Fujiwara Y. Citric acid inhibits development of cataracts, proteinuria and ketosis in streptozotocin (type 1) diabetic rats. Biochem. Biophys. Res. Commun., 393, 118-122 (2010).
    • (2010) Biochem. Biophys. Res. Commun. , vol.393 , pp. 118-122
    • Nagai, R.1    Nagai, M.2    Shimasaki, S.3    Baynes, J.W.4    Fujiwara, Y.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.